✦ LIBER ✦

Initial Trials of Anti-CD80 Monoclonal Antibody (Galiximab) Therapy for Patients with Relapsed or Refractory Follicular Lymphoma

✍ Scribed by Younes, Anas; Hariharan, Kandasamy; Allen, Roberta S.; Leigh, Bryan R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of LY2469298, an Fc-engine

✍ Kensei Tobinai; Michinori Ogura; Yukio Kobayashi; Toshiki Uchida; Takashi Watana 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

Phase II Trial of Remitogen™ (Humanized

✍ Brown, Kevin S.; Levitt, Daniel J.; Shannon, Mary; Link, Brian K. 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 94 KB

Phase III Trial of a Humanized Anti-CD33

✍ Gibson, Angelia D.; Tallman, Martin S.; Jain, Vinay K. 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 87 KB

A phase 1 study of lucatumumab, a fully

✍ William Bensinger; Richard T. Maziarz; Sundar Jagannath; Andrew Spencer; Simon D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Phase II trial of 131I-B1 (anti-CD20) an

✍ O.W Press; F Appelbaum; P.J Martin; D.C Matthews; I.D Bernstein; J.F Eary; W.B N 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 699 KB

Tandem high-dose therapy in relapsed and

✍ Karin Hohloch; Carsten Oliver Sahlmann; Vijai J. Lakhani; Gerald Wulf; Bertram G 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 233 KB